Business · 01/08/2019
FDA Releases Draft Guidance on Pathology Peer Review in Nonclinical Toxicology Studies
The FDA has released a draft guidance to clarify the management, conduct, and documentation of pathology peer review in nonclinical toxicology studies, addressing current practices that vary among testing facilities.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →